Materiały źródłowe

• #1 Dwarfism (Skeletal Dysplasia) & Other Causes of Short Stature

  https://my.clevelandclinic.org/health/diseases/17862-skeletal-dysplasia-dwarfism-and-other-causes-of-short-stature

  Dwarfism (skeletal dysplasia) is a medical term that covers hundreds of conditions that affect the growth of bone and/or cartilage, and the size of a persons arms, legs, abdomen and head. Treatment manages symptoms and leads to a normal lifespan for many types. […] Treatment for dwarfism (skeletal dysplasia) is unique for each person based on their specific diagnosis and addresses symptoms of the condition, since theres no cure. […] Surgical treatment to address symptoms could include surgery to: Correct bones growing in an abnormal direction or the shape of bones. Remove excess fluid from around the brain (hydrocephalus). Reduce brain stem compression, which is pressure on the part of the brain that connects to the spinal cord. Improve breathing by removing tonsils and/or adenoids. Add tubes in the ears to prevent ear infections.

• #1 Dwarfism: Types, Causes, Treatments, and More

  https://www.webmd.com/children/dwarfism-causes-treatments

  Dwarfism Treatments Early diagnosis and treatment can help prevent or lessen some of the problems that come with dwarfism. People with dwarfism related to growth hormone deficiency can be treated with growth hormone. For children with achondroplasia who still have the potential for growth, the FDA has approved vosoritide (Voxzogo) to help stimulate bone growth. […] In many cases, people with dwarfism have orthopedic or medical complications. Treatment of those can include: Insertion of a shunt to drain excess fluid and relieve pressure on the brain, A tracheotomy to improve breathing through small airways, Corrective surgeries for deformities such as cleft palate, club foot, or bowed legs, Surgery to remove tonsils or adenoids to improve breathing problems related to large tonsils, small facial structures, and/or a small chest, Surgery to widen the spinal canal (the opening through which the spinal cord passes) to relieve spinal cord compression, Extended limb lengthening, a controversial surgery, due in part to its risks, involves several procedures. It is only done on adults.

• #1 Dwarfism – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK563282/

  Dwarfism is the medical terminology for short-stature. This activity outlines the evaluation and management of dwarfism and highlights the interprofessional team’s role in managing patients with this condition. […] Review the management options available for dwarfism. […] Recombinant human growth hormone therapy (rhGH) is an effective treatment for patients suffering from growth hormone deficiency. Early intervention can prevent short stature and the psychosocial stress associated with it. […] For patients with idiopathic short stature (ISS), commencing GH therapy can enhance the growth velocity and mean adult height. […] Gonadotropin-releasing hormone (GnRH) analogs are used to halt the progression of precocious puberty. […] The child receives daily subcutaneous growth hormone (GH) injections, and are advised to take GH injections regularly, preferably within 1 hour of sleep every night, at a specific time, and not to miss more than one dose a month.

• #1 Restricted growth (dwarfism)

  https://www.nhs.uk/conditions/restricted-growth/

  The main treatment for restricted growth is growth hormone medicine. […] Surgery to increase the length of your arms or legs is sometimes done, but this is rare. […] Growth hormone is used to increase height in children with restricted growth, or children who are not growing as expected for their age. […] It can treat many different types of restricted growth, but it is not normally used to treat a problem with bone development (such as achondroplasia and other skeletal dysplasias). […] How well treatment works depends on what’s causing the restricted growth. Treatment usually continues until your child stops growing or reaches their target height. […] If you have a skeletal dysplasia such as achondroplasia, treatment usually aims to relieve any other symptoms you have, rather than increase your height. […] Treatments you may need include: physiotherapy for problems with movement and pain, orthodontics for problems with your teeth, treatment for ear infections and sleep apnoea, surgery, for example to straighten bowed legs, or to straighten or reduce pressure on your spine.

• #1 FDA Approves First Drug to Improve Growth in Children with Most Common Form of Dwarfism | FDA

  https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-improve-growth-children-most-common-form-dwarfism

  Today, the U.S. Food and Drug Administration approved Voxzogo (vosoritide) injection to improve growth in children five years of age and older with achondroplasia and open epiphyses (growth plates), meaning these children still have the potential to grow. Achondroplasia is the most common form of dwarfism. […] With this action, children with short stature due to achondroplasia have a treatment option that targets the underlying cause of their short stature. […] Voxzogo works by binding to a specific receptor called natriuretic peptide receptor-B that reduces the growth regulation genes activity and stimulates bone growth. […] Voxzogos safety and efficacy in improving growth were evaluated in a year-long, double-blind, placebo-controlled, phase 3 study in participants five years and older with achondroplasia who have open epiphyses.

• #1 New treatment for people with dwarfism | European Medicines Agency (EMA)

  https://www.ema.europa.eu/en/news/new-treatment-people-dwarfism

  EMA has recommended granting a marketing authorisation in the European Union (EU) for Voxzogo (vosoritide) for the treatment of achondroplasia, a condition that impairs bone growth and causes dwarfism. […] The medicine is intended for use in patients 2 years and older whose epiphyses (growth plates of the bones) are not yet closed. […] In patients with achondroplasia the fibroblast growth-factor receptor 3 (FGFR3) gene is permanently switched on, preventing normal bone growth. Vosoritide, the active substance in Voxzogo, works by attaching to a receptor called natriuretic peptide receptor type B (NPR-B) on the surface of cells. The activation of this receptor will reduce the activity of FGFR3 and thereby stimulate the normal growth of bones and improve the symptoms of the disease. […] The opinion of EMAs human medicines committee (CHMP) is mainly based on one study which evaluated 121 patients with achondroplasia who were between 5 and 18 years of age. During the course of the study, a statistically significant improvement in growth was observed in patients treated with vosoritide compared to placebo, adding an average 1.57 cm in height after a year of treatment. […] A separate ongoing study including subjects aged 2 to 5 also suggests consistent improvement in growth.

• #1 FDA approval grows use of growth therapy for children with achondroplasia  – CHOC Pediatrica

  https://care.choc.org/fda-approval-grows-use-of-growth-therapy-for-children-with-achondroplasia/

  FDA approval grows use of growth therapy for children with achondroplasia. The most common type of dwarfism, achondroplasia can now be treated with Voxzogo starting at birth, maximizing children’s growth potential. In November 2021, the FDA approved Voxzogo (vosoritide) to assist with linear growth in children ages 5 and older with achondroplasia whose growth plate remained open. At the end of 2023, the FDA extended approval to children of all ages with achondroplasia with open growth plates. Many suspect this increased candidacy will further improve care of children with achondroplasia, the most common form of dwarfism. Starting earlier, then, signifies a large step toward helping children with achondroplasia reach their growth potential. After a child receives a diagnosis of achondroplasia, the newly updated approval permits them to begin a regimen of Voxzogo at any age. Administered daily via subcutaneous injection, Voxzogo affects linear growth by working on the growth plates of the endochondral bone — primarily long bones. In early studies, children ages 5 and older grew an average of 1.57 centimeters more in one year than their peers who received a placebo. The growth response is better than what is documented. Within the first year, some patients respond so well to Voxzogo that they grow as much as 7 centimeters. Because of this positive safety profile, the door seems wide open for long-term use of Voxzogo without the potential for negative consequences. Knowing this provides confidence for clinicians to prescribe continual use of Voxzogo from birth until the growth plates close. To keep the growth plates open as long as possible, pediatric endocrinologists prescribe aromatase inhibitors. The goal of Voxzogo use is improved linear growth or height in patients that permits them to engage in normal, independent daily living. Thus far, clinicians have reported each of these improvements at various times. Preliminary data indicates that earlier treatment improves proportionate growth of the extremities while reducing spinal thoracolumbar kyphosis and genu varum. There is continual work to develop longer-acting subcutaneous formulation and other agents that can be taken orally for treatment of achondroplasia.

• #1 Study Results Promising for Achondroplasia Treatment – Jacobs School of Medicine and Biomedical Sciences – University at Buffalo

  https://medicine.buffalo.edu/news_and_events/news/2023/11/quattrin-achondroplasia-accomplish-18504.html

  Teresa Quattrin, MD, UB Distinguished Professor of pediatrics, is a co-author on a new global study that suggests a novel treatment option for children with achondroplasia a form of severe short stature. […] The study, Once-Weekly TransCon CNP (Navepegritide) in Children With Achondroplasia (ACcomplisH): A Phase 2, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Dose-Escalation Trial, was published Oct 2. in eClinical Medicine, a part of The Lancet Discovery Science journal. […] At the 100 g CNP/kg/week dose, TransCon CNP demonstrated significantly improved annualized growth velocity compared to the placebo, the study found, providing the first evidence that TransCon CNP significantly increased annualized growth velocity in children with achondroplasia with a favorable safety profile.

• #1 Achondroplasia Treatment & Management: Approach Considerations, Medical Care, Surgical Care

  https://emedicine.medscape.com/article/1258401-treatment

  Approval was supported by outcomes of a global randomized double-blind placebo-controlled phase 3 study evaluating efficacy and safety in 121 children (age, 5-14 y) with achondroplasia over a period of 52 weeks. […] Other agents being evaluated for potential use in treating achondroplasia include FGFR3-selective tyrosine kinase inhibitors, anti-FGFR3 antibodies, aptamers against fibroblast growth factor 2 (FGF2), and soluble forms of FGFR3. […] Most of the orthopedic problems encountered in patients with achondroplasia are related to the spine. […] Surgical correction of genu varum may be required. […] Limb lengthening of the upper and lower extremities is promoted in Europe. […] If lengthening is to be performed, any existing angular deformities should be corrected simultaneously.

• #1 Gene therapy: A potential cure for growth-hormone resistant dwarfism

  https://www.drugtargetreview.com/news/103053/gene-therapy-a-potential-cure-for-growth-hormone-resistant-dwarfism/

  Researchers have shown that gene therapy using a single-dose injection of a virus carrying the good gene could possibly be used to cure growth-hormone resistant dwarfism. […] A new study from the NUS Yong Loo Lin School of Medicine (NUS Medicine), Singapore has shown that gene therapy using a single-dose injection of a virus carrying the good gene can potentially be used to cure growth-hormone resistant dwarfism, also known as Laron Syndrome. […] Gene therapy has given us a promising start in managing dwarfism. This is far more favourable compared to rhIGF1 injections, once or twice daily for many years, which causes side effects of pain and discomfort to patients and comes as a huge financial burden to those involved, concluded Professor Lee K O, research lead.

• #1 First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model | Gene Therapy

  https://www.nature.com/articles/s41434-022-00313-w

  The only treatment tested for growth hormone receptor (GHR) defective Laron Syndrome (LS) is injections of recombinant insulin-like-growth factor 1 (rhIGF1). […] Our study is the first to use gene therapy to treat GH-receptor deficiency. We propose that gene therapy with AAV-GHR may eventually be useful for the treatment of human LS. […] To our knowledge, this is the first reported pre-clinical gene therapy treatment of an established model of the Laron Syndrome (LS), i.e., the GHR/ or knockout mice using an AAV8 vector directing expression of mouse GHR (mGHR) to the liver. […] We aimed to investigate if a single dose of AAV8-mediated liver expression of mGHR was sufficient to treat Laron dwarf mice, as a proof of concept for development of a treatment for patients with LS. […] Gene therapy using an AAV viral vector has emerged as a safe and efficient gene delivery tool with the potential to treat a variety of inherited or rare mutation disorders that previously were untreatable, such as hemophilia, Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), Pompe disease etc.

• #1 Achondroplasia Treatment – MU Health Care – Columbia, MO

  https://www.muhealth.org/conditions-treatments/pediatrics/orthopaedics/skeletal-dysplasia/achondroplasia

  Persistent kyphotic curves occur in approximately 10%-15% of children with achondroplasia, in which case a clinical follow-up with spine X-rays is recommended. Treatment varies depending on the degree of kyphosis present, measured using a Cobb angle. […] Surgical intervention is typically not necessary but may be needed if the patient experiences extremity pain or if a lateral thrust is observed. Surgery should be performed by an orthopaedic doctor that specializes in skeletal dysplasia and may include derotational osteotomy or 8-plate. […] If treatment is required, a subocciptal decompression is necessary to relieve the compression of the respiratory centers and nerves. […] Treatment can include oxygen supplementation (used in a small percentage of patients) or a cervical decompression to treat foramen magnum compression. […] There are several options for treatment, depending on the severity of the apnea: Adenoidectomy and/or tonsillectomy, CPAP machine use, BIPAP machine use. […] Myringotomy and pressure equalizing tubes should be used aggressively.

• #1 Dwarfism: Types, Causes, and More

  https://www.healthline.com/health/dwarfism

  Dwarfism, regardless of the cause, cant be cured or corrected. However, there are certain therapies that may help reduce the risk of complications. […] For people with growth hormone deficiency, injections of synthetic human growth hormone may be helpful. Children receiving this treatment dont always reach an average height, but they can get close. […] Girls with Turners syndrome need estrogen therapy and other hormones to help trigger puberty and appropriate female development. Estrogen therapy may be necessary until a woman reaches the age of menopause. […] For others with dwarfism, surgical treatments may be necessary and helpful to living a longer, healthier life. […] Surgical treatments include those that can help: correct the direction of bone growth, stabilize the spine, increase the channel in the vertebrae surrounding the spinal cord to relieve pressure on the spinal cord.

• #1 Achondroplasia Treatment West Palm Beach, FL | Dwarfism Treatment New Yrok, NY

  https://www.davidsfeldmanmd.com/achondroplasia-orthopedic-surgeon-west-palm-beach.html

  None of us at the Paley Institute would lengthen a patient until their spine is cleared. […] Yearly x-rays and asking questions, beginning in childhood and continuing throughout the patients life, are important in determining if treatment is needed. […] Limb lengthening is a personal decision to be made by the patient and their family. Any person interested in lengthening should ensure they elect to have it done at a specialized center with extensive experience.

• #1 Dwarfism | International Center for Limb Lengthening

  https://www.limblength.org/conditions/dwarfism/

  Chandler, a patient with achondroplasia, started her lengthening treatments at the International Center for Limb Lengthening at the age of 16. […] Not every patient with dwarfism requires treatment; it is a very personal decision made after weighing the risks and benefits. […] Our most common goals of treatment are: to obtain a functional height, normally between 4 feet and 10 inches (147 cm) and 5 feet and 2 inches (157 cm); to correct deformities like bowlegs to improve walking; to lengthen the arms to a functional length for self-care and driving; and to gain secondary psychological benefits from a more positive body image and body function. […] For patients who elect to lengthen, after undergoing several phases of lengthening at the International Center for Limb Lengthening, most girls achieve a height of 5 feet (152 cm) and most boys achieve a height of 5 feet 2-4 inches (157-163 cm).

• #1 Dwarfism | International Center for Limb Lengthening

  https://www.limblength.org/conditions/dwarfism/

  The International Center for Limb Lengthenings pediatric orthopedics physicians have partnered with the Pediatric Endocrinology Division at the Herman Walter Samuelson Childrens Hospital at Sinai to offer BioMarins VOXZOGO, also known as vosoritide, an injectable prescription medication that has been FDA-approved to increase linear growth for children with achondroplasia who are five years of age and older and still have open growth plates. […] Limb deformity correction can occur at any age. […] While some patients choose to start in their late teens or early twenties, it is much harder to achieve as much height starting that late in life. […] The approximate total increase in lower limb length is 8-10 inches (20-25 cm) and the approximate total increase in upper limb length is 3-4 inches (7.6-10 cm).

• #1 Dwarfism: Types, Causes, Treatments, and More

  https://www.webmd.com/children/dwarfism-causes-treatments

  Other treatment may include: Physical therapy to strengthen muscles and increase joint range of motion, Back braces to improve curvature of the spine, Placement of drainage tubes in the middle ear to help prevent hearing loss due to repeated ear infections, Orthodontic treatment to relieve crowding of teeth caused by a small jaw, Nutritional guidance and exercise to help prevent obesity, which can worsen skeletal problems.

• #1 Dwarfism: Types, Causes, and More

  https://www.healthline.com/health/dwarfism

  Physical therapy and orthotics are noninvasive solutions to some complications of dwarfism. Physical therapy is often prescribed after limb or back surgery to help you regain or improve your range of motion and strength. Physical therapy may also be advised if dwarfism is affecting the way you walk or is causing you pain that doesnt require surgery. […] Orthotics are custom-made devices that fit into your shoes to help improve your foot health and function. If dwarfism is affecting your balance, how you walk, or other aspects of foot function, talk with a podiatrist about how orthotics may help you.

• #1 New Achondroplasia treatments 2025 | Everyone.org

  https://everyone.org/explore/treatment/?id=97

  However, clinical evidence supporting its efficacy is limited and inconsistent. […] Physical therapy and occupational therapy play essential roles in managing achondroplasia by improving mobility, strength, coordination, and independence in daily activities. […] Several experimental treatments are currently under clinical investigation for achondroplasia. […] Voxzogo represents a significant advancement as an FDA-approved medication targeting growth impairment; however, it does not address all clinical manifestations of achondroplasia. […] Experimental treatments such as infigratinib, recifercept, and gene therapy approaches hold promise but require further research and clinical validation. […] Management of achondroplasia involves a comprehensive, multidisciplinary approach that includes medical, surgical, and supportive therapies.

• #1 Dwarfism (Skeletal Dysplasia) & Other Causes of Short Stature

  https://my.clevelandclinic.org/health/diseases/17862-skeletal-dysplasia-dwarfism-and-other-causes-of-short-stature

  Other types of treatment to address symptoms of dwarfism (skeletal dysplasia) that dont involve surgery include: Using a CPAP (continuous positive airway pressure) machine for sleep apnea. Using hearing aids to improve hearing. Encouraging healthy eating habits and exercise to prevent excess weight gain or obesity (a BMI, or body mass index, of 30 or higher). Taking growth hormones (hormone therapy) to treat a growth hormone deficiency. In 2021, the U.S. Food and Drug Administration approved the use of vosoritide (Voxzogo) in children with achondroplasia who are 5 years and older but whose bone growth plates are still open (this means theyre not finished growing yet). In a clinical trial, vosoritide helped speed childrens growth. […] Treatment for dwarfism is lifelong and helps improve a persons quality of life.

• #1 Achondroplasia Treatment & Management: Approach Considerations, Medical Care, Surgical Care

  https://emedicine.medscape.com/article/1258401-treatment

  A potential exists for major complications during six-segment lengthening. […] Significant improvement of severe neurologic symptoms has been reported with foramen magnum decompression and C1 laminectomy; however, prophylactic surgery is not recommended. […] Nutritional counseling is helpful. Obesity is a lifelong issue, and dietary therapy should be initiated early in life.

• #1 Support for Achondroplasia in Children | NYU Langone Health

  https://nyulangone.org/conditions/achondroplasia-in-children/support

  The doctors at Hassenfeld Childrens Hospital at NYU Langone address all aspects of care for children with achondroplasia. This includes a number of services to help children and their families cope with many of the practical aspects of life with achondroplasia. […] Children with achondroplasia often benefit from comprehensive rehabilitation services, including physical and occupational therapy, to cope with physical challengesfor example, trying to grasp something thats out of reach. […] Physical and occupational therapists also help people with achondroplasia to recover from bone or spinal surgery. […] Our physiatrists also provide guidance and support to help your child become actively engaged in sports and other recreational activities at home and school. […] Nutritionists at Hassenfeld Childrens Hospital offer advice about healthy eating in young children with achondroplasia, suggesting diets that can help to prevent obesity and complications, such as sleep apnea. […] Our psychologists can help children and families to work through the challenges of living with achondroplasia.

• #1 Achondroplasia – Wikipedia

  https://en.wikipedia.org/wiki/Achondroplasia

  Treatments include small molecule therapy with a C-natriuretic peptide analog (vosoritide), approved to improve growth velocity in children with achondroplasia based on results in Phase 3 human trials, although its long-term effects are unknown. […] Growth hormone therapy may also be used. […] Efforts to treat or prevent complications such as obesity, hydrocephalus, obstructive sleep apnea, middle ear infections or spinal stenosis may be required. […] Research has also shown that introducing parents of children with achondroplasia to support and advocacy groups at the time of diagnosis can improve outcomes. […] Limb-lengthening will increase the length of the legs and arms of someone with achondroplasia, but little medical consensus exists regarding this practice. […] Homozygous achondroplasia is invariably considered terminal even with aggressive treatment.

• #1 Consensus Guidelines for Vosoritide Therapy for Achondroplasia / Dwarfism – Guideline Summary

  https://www.guidelinecentral.com/guideline/4475574/

  R1. Education and resources should be available to primary care physicians to support initial contact with patients and care-givers; communication with experts is important given further emerging clinical evidence for vosoritide (strong recommendation, Delphi 100%). […] R2. Patients should be referred to an expert centre as soon as diagnosis is suspected to begin discussions and enable treatment to commence as early as possible (strong recommendation, Delphi 94%).

• #1 Vosoritide: MedlinePlus Drug InformationLock

  https://medlineplus.gov/druginfo/meds/a622012.html

  Vosoritide is used to increase linear growth (height) in certain children who have achondroplasia (ACH; achondroplastic dwarfism; a genetic condition of bone growth that results in short arms and legs). Vosoritide is in a class of medications called C type natriuretic peptide (CNP) analogs. It works by increasing cartilage cell growth which results in increased bone growth. […] Your healthcare provider will monitor your child’s growth carefully during treatment with vosoritide injection and will adjust the dose and the length of treatment based on your child’s response to this medication. […] This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

• #1 A to Z: Pituitary Dwarfism | Dayton Children’s Hospital

  https://www.childrensdayton.org/kidshealth/a/az-pituitary-dwarfism

  Pituitary dwarfism, or growth hormone deficiency, is a condition in which the pituitary gland does not make enough growth hormone. This results in a child’s slow growth pattern and an unusually small stature (below average height). […] Pituitary dwarfism is treated with regular injections of synthetic human growth hormone before a child’s growth plates have joined together. It can be difficult to manage, however, and success rates vary. […] Children with pituitary dwarfism have normal intelligence and with early detection and treatment, many of them can also reach a normal height.

• #1 Treatment of Dwarfism With Recombinant Human Insulin-Like Growth Factor-1

  https://pmc.ncbi.nlm.nih.gov/articles/PMC2780013/

  The growth hormone-IGF (insulin-like growth factor) system plays a central role in hormonal growth regulation. Recombinant human (rh) growth hormone (GH) has been available since the late 1980s for replacement therapy in GH-deficient patients and for the stimulation of growth in patients with short stature of various causes. Growth promotion by GH occurs in part indirectly through the induction of IGF-1 synthesis. In primary disturbances of IGF-1 production, short stature can only be treated with recombinant human IGF-1 (rhIGF-1). rhIGF-1 was recently approved for this indication but can also be used to treat other conditions. […] In children with severe primary IGF-1 deficiency (a rare condition whose prevalence is less than 1:10 000), the prognosis for final height is very poor (ca. 130 cm), and IGF-1 therapy is the appropriate form of pathophysiologically based treatment. There is no alternative treatment at present. The subcutaneous administration of IGF-1 twice daily in doses of 80 to 120 g/kg accelerates growth and increases final height by 12 to 15 cm, according to current data. There is, however, a risk of hypoglycemia, as IGF-1 has an insulin-like effect. As treatment with IGF-1 is complex, this new medication should only be prescribed, for the time being, by experienced pediatric endocrinologists and diabetologists.

• #1 Dwarfism // Middlesex Health

  https://middlesexhealth.org/learning-center/diseases-and-conditions/dwarfism

  Treatment for girls with Turner syndrome also requires estrogen and related hormone therapy to start puberty and lead to adult sexual development. Estrogen replacement therapy usually continues until the average age of menopause. […] Surgical procedures that may correct problems in people with disproportionate dwarfism include: Correcting the direction the bones grow in. Stabilizing and correcting the shape of the spine. Increasing the size of the opening in bones of the spine, called vertebrae, to ease pressure on the spinal cord. Placing a shunt to remove too much fluid around the brain also known as hydrocephalus if it occurs. […] Regular checkups and ongoing care by a healthcare professional familiar with dwarfism can make quality of life better. Because there is a range of symptoms and complications, conditions are managed as they happen, such as tests and treatment for ear infections, spinal stenosis or sleep apnea. […] Adults with dwarfism should continue to be monitored and treated for conditions that occur throughout life.

• #1 Dwarfism (Restricted Growth): Types and Causes

  https://patient.info/bones-joints-muscles/restricted-growth-dwarfism

  For a person with an unusual syndrome resulting in a number of medical problems, often a team of health professionals is involved to help. […] In many countries there are websites for support groups with more information for people either with dwarfism or with the specific conditions causing it. Some of those in the UK are listed in the further reading section below.

• #1 Dwarfism

  https://www.mymlc.com/health-information/diseases-and-conditions/d/dwarfism2/?section=Symptoms

  Treatment for girls with Turner syndrome also requires estrogen and related hormone therapy in order for them to begin puberty and achieve adult sexual development. Estrogen replacement therapy usually continues throughout life until women with Turner syndrome reach the average age of menopause. […] Regular checkups and ongoing care by a doctor familiar with dwarfism can improve quality of life. Because of the range of symptoms and complications, treatments are tailored to address problems as they occur, such as assessment and treatment for ear infections, spinal stenosis or sleep apnea. […] Some people with dwarfism choose to undergo surgery called extended limb lengthening. This procedure is controversial for many people with dwarfism because, as with all surgeries, there are risks. Waiting to decide about limb lengthening until the person with dwarfism is old enough to participate in the decision is recommended because of the emotional and physical stress involved with multiple procedures.

• #1 Achondroplasia Treatment West Palm Beach, FL | Dwarfism Treatment New Yrok, NY

  https://www.davidsfeldmanmd.com/achondroplasia-orthopedic-surgeon-west-palm-beach.html

  Long bone lengthening and/or deformity correction of the upper and lower extremities, with my team and me, at the Paley Orthopedic and Spine Institute can be done safely and reliably with impressive results. […] IT IS PREVENTABLE AND TREATABLE. […] Yearly examinations and discussions of symptoms are required. If symptoms are occurring, even mild, an MRI will demonstrate the extent and location of the spinal compression. Surgery to decompress the stenosis to unroof the compression is often curative. […] A spinal fusion is necessary if the decompression requires removal of the joints or if there is kyphosis (hunch back), as often encountered in Achondroplasia. […] When performed correctly and for the right indications, it allows the individuals to return to normal. […] In order to enhance the fusion, I now do a minimally invasive side surgery at the same time at the lowest level to assure fusion, which is a problem when so much bone is removed to decompress.

• #1 Osteochondrodysplasias (Osteochondrodysplastic Dwarfism) – Pediatrics – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/pediatrics/connective-tissue-disorders-in-children/osteochondrodysplasias-osteochondrodysplastic-dwarfism

  Osteochondrodysplasias involve abnormal bone or cartilage growth, leading to skeletal maldevelopment, often short-limbed dwarfism. Diagnosis is by physical examination, x-rays, and, in some cases, genetic testing. Treatment is surgical. […] In achondroplasia, treatment with human growth hormone is generally not effective. However, vosoritide (a C-type natriuretic peptide analog) is available and has shown encouraging results in studies in facilitating bone growth. […] An increase in adult height may be achieved by surgical limb-lengthening. Bowlegs can be corrected surgically. In achondroplasia and other nonlethal osteochondrodysplasias, surgery (eg, hip replacement) can help improve joint function. […] Because the inheritance pattern and gene mutations in most types are known, genetic counseling can be effective. […] Growth hormone treatments are typically ineffective.

• #1 Dwarfism – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK563282/

  The normal variants of short stature can expect to lead healthy lives. The patients suffering from GHD can benefit from recombinant human growth hormone therapy and generally attain heights similar to their parents, given that the treatment is commenced before puberty. […] The complications which are associated with GH therapy are- possible predisposition to type-2 diabetes, benign intracranial hypertension, edema/carpal tunnel syndrome, slipped capital femoral epiphysis (SCFE), scoliosis, prepubertal gynecomastia.

• #1 First Drug to Boost Growth in Children With Dwarfism – QPS

  https://www.qps.com/2022/01/31/approved-first-drug-to-boost-growth-in-children-with-dwarfism/

  The first drug to counter the genetic mutation that causes achondroplasia, the most common form of dwarfism, received accelerated FDA approval in November. BioMarin Pharmaceuticals Voxzogo (vosoritide), a daily injection, was approved for children aged five and older. […] A one-year phase 3 study of 121 children found that those who received the drug grew an average 1.57 cm taller compared to those who received a placebo. […] The treatment can continue until a child’s growth plates have closed, typically around age 18. […] Voxzogo works by binding to a receptor called natriuretic peptide receptor-B, reducing the gene’s activity. […] Voxzogo represents a welcome treatment option for many families. […] As a parent of a child with achondroplasia, I see the availability of treatments that impact bone growth as an important step forward, Haider said. […] In the meantime, research will continue to determine if Voxzogo and similar drugs can prevent the medical complications of achondroplasia.

• #1 Advantages and Disadvantages of Different Treatment Methods in Achondroplasia: A Review

  https://www.mdpi.com/1422-0067/22/11/5573

  The long-term effects of PTH treatment are unknown, and further studies on the safety profile are required, but recombinant human PTH may be a potential treatment option for achondroplasia. […] All of the aforementioned potential therapeutic medications that are currently being explored have advantages as well as disadvantages, which are summarized in Table 2 and Table 3. There is a risk that a cure for all ailments will not be found. In that case, perhaps a therapy that involves the combined use of several different drugs should be tested. There are already precedents confirming the efficacy of such a procedure. A great example is the use of the phosphatase inhibitor LB-100 in combination with BMN-111. Their synergistic effects in increasing growth in bone length have been demonstrated.

• #2 Dwarfism: Types, Causes, Treatments, and More

  https://www.webmd.com/children/dwarfism-causes-treatments

  Dwarfism Treatments Early diagnosis and treatment can help prevent or lessen some of the problems that come with dwarfism. People with dwarfism related to growth hormone deficiency can be treated with growth hormone. For children with achondroplasia who still have the potential for growth, the FDA has approved vosoritide (Voxzogo) to help stimulate bone growth. […] In many cases, people with dwarfism have orthopedic or medical complications. Treatment of those can include: Insertion of a shunt to drain excess fluid and relieve pressure on the brain, A tracheotomy to improve breathing through small airways, Corrective surgeries for deformities such as cleft palate, club foot, or bowed legs, Surgery to remove tonsils or adenoids to improve breathing problems related to large tonsils, small facial structures, and/or a small chest, Surgery to widen the spinal canal (the opening through which the spinal cord passes) to relieve spinal cord compression, Extended limb lengthening, a controversial surgery, due in part to its risks, involves several procedures. It is only done on adults.

• #2 Dwarfism – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK563282/

  Dwarfism is the medical terminology for short-stature. This activity outlines the evaluation and management of dwarfism and highlights the interprofessional team’s role in managing patients with this condition. […] Review the management options available for dwarfism. […] Recombinant human growth hormone therapy (rhGH) is an effective treatment for patients suffering from growth hormone deficiency. Early intervention can prevent short stature and the psychosocial stress associated with it. […] For patients with idiopathic short stature (ISS), commencing GH therapy can enhance the growth velocity and mean adult height. […] Gonadotropin-releasing hormone (GnRH) analogs are used to halt the progression of precocious puberty. […] The child receives daily subcutaneous growth hormone (GH) injections, and are advised to take GH injections regularly, preferably within 1 hour of sleep every night, at a specific time, and not to miss more than one dose a month.

• #2 Restricted growth (dwarfism)

  https://www.nhs.uk/conditions/restricted-growth/

  The main treatment for restricted growth is growth hormone medicine. […] Surgery to increase the length of your arms or legs is sometimes done, but this is rare. […] Growth hormone is used to increase height in children with restricted growth, or children who are not growing as expected for their age. […] It can treat many different types of restricted growth, but it is not normally used to treat a problem with bone development (such as achondroplasia and other skeletal dysplasias). […] How well treatment works depends on what’s causing the restricted growth. Treatment usually continues until your child stops growing or reaches their target height. […] If you have a skeletal dysplasia such as achondroplasia, treatment usually aims to relieve any other symptoms you have, rather than increase your height. […] Treatments you may need include: physiotherapy for problems with movement and pain, orthodontics for problems with your teeth, treatment for ear infections and sleep apnoea, surgery, for example to straighten bowed legs, or to straighten or reduce pressure on your spine.

• #2 Achondroplasia: Signs, Symptoms and Prevention of Complications

  https://www.nationwidechildrens.org/conditions/achondroplasia

  Children with achondroplasia can lead normal lives provided they receive appropriate care and follow-up by knowledgeable providers. […] Although the cause of achondroplasia is known, there is currently no known treatment for the underlying condition itself. Human growth hormone has been used to treat other types of dwarfism but has not proven beneficial for patients with achondroplasia. Overall, most treatment involves prevention and treatment of complications related to achondroplasia. Babies with achondroplasia need to be monitored for problems with too much fluid on the brain (hydrocephalus) and may require a shunt to drain the fluid. Similarly, some babies may need the base of the skull (foramen magnum) to be surgically enlarged to prevent spinal cord compression. It is important children with achondroplasia receive timely dental care to prevent tooth overcrowding. Treating and preventing ear infections to prevent long-term hearing loss is critical. Limb-lengthening is a controversial treatment to increase the overall height and limb length of patients with achondroplasia. Preventing obesity, to reduce joint and back problems, is also important. Some patients may require a laminectomy for spinal stenosis as young adults.

• #2 FDA approval grows use of growth therapy for children with achondroplasia  – CHOC Pediatrica

  https://care.choc.org/fda-approval-grows-use-of-growth-therapy-for-children-with-achondroplasia/

  FDA approval grows use of growth therapy for children with achondroplasia. The most common type of dwarfism, achondroplasia can now be treated with Voxzogo starting at birth, maximizing children’s growth potential. In November 2021, the FDA approved Voxzogo (vosoritide) to assist with linear growth in children ages 5 and older with achondroplasia whose growth plate remained open. At the end of 2023, the FDA extended approval to children of all ages with achondroplasia with open growth plates. Many suspect this increased candidacy will further improve care of children with achondroplasia, the most common form of dwarfism. Starting earlier, then, signifies a large step toward helping children with achondroplasia reach their growth potential. After a child receives a diagnosis of achondroplasia, the newly updated approval permits them to begin a regimen of Voxzogo at any age. Administered daily via subcutaneous injection, Voxzogo affects linear growth by working on the growth plates of the endochondral bone — primarily long bones. In early studies, children ages 5 and older grew an average of 1.57 centimeters more in one year than their peers who received a placebo. The growth response is better than what is documented. Within the first year, some patients respond so well to Voxzogo that they grow as much as 7 centimeters. Because of this positive safety profile, the door seems wide open for long-term use of Voxzogo without the potential for negative consequences. Knowing this provides confidence for clinicians to prescribe continual use of Voxzogo from birth until the growth plates close. To keep the growth plates open as long as possible, pediatric endocrinologists prescribe aromatase inhibitors. The goal of Voxzogo use is improved linear growth or height in patients that permits them to engage in normal, independent daily living. Thus far, clinicians have reported each of these improvements at various times. Preliminary data indicates that earlier treatment improves proportionate growth of the extremities while reducing spinal thoracolumbar kyphosis and genu varum. There is continual work to develop longer-acting subcutaneous formulation and other agents that can be taken orally for treatment of achondroplasia.

• #2 FDA Approves First Drug to Improve Growth in Children with Most Common Form of Dwarfism | FDA

  https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-improve-growth-children-most-common-form-dwarfism

  Today, the U.S. Food and Drug Administration approved Voxzogo (vosoritide) injection to improve growth in children five years of age and older with achondroplasia and open epiphyses (growth plates), meaning these children still have the potential to grow. Achondroplasia is the most common form of dwarfism. […] With this action, children with short stature due to achondroplasia have a treatment option that targets the underlying cause of their short stature. […] Voxzogo works by binding to a specific receptor called natriuretic peptide receptor-B that reduces the growth regulation genes activity and stimulates bone growth. […] Voxzogos safety and efficacy in improving growth were evaluated in a year-long, double-blind, placebo-controlled, phase 3 study in participants five years and older with achondroplasia who have open epiphyses.

• #2 Study Results Promising for Achondroplasia Treatment – Jacobs School of Medicine and Biomedical Sciences – University at Buffalo

  https://medicine.buffalo.edu/news_and_events/news/2023/11/quattrin-achondroplasia-accomplish-18504.html

  Quattrin says one of the breakthrough successes of the ACcomplisH trial is the use of weekly injections instead of daily. […] The researchers consider that the trial results suggest TransCon CNP to be a promising once-weekly treatment option for children with achondroplasia through continuous exposure of unmodified CNP and low Cmax, which can offer a holistic benefit and reduced burden of care on children and caregivers.

• #2 First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model | Gene Therapy

  https://www.nature.com/articles/s41434-022-00313-w

  Here, we have successfully demonstrated for the first time that the AAV vector can be used to treat Laron dwarfism with a single AAV injection dose using a mouse model with disruption of the mGHR gene. […] Our findings showed that a single intraperitoneal dose of AAV8-HLP-mGHR (41010 vg/mouse) into 45-week-old Laron dwarf mice resulted in sufficient expression of mGHR in the liver to restore GH signaling resulting in increased circulating IGF1, IGFBP3 and ALS. […] Our treatment of Laron mice resulted in a similar partial restoration of body length where the AAV8-HLP-mGHR treated mice had grown at near normal rates after 3-week post AAV injection but did not display catch up growth to normal. […] Despite its limitations, this study provides evidence that single administration of AAV8-HLP-mGHR viral vector can increase the expression of endogenously circulating IGF1, IGFBP3 and ALS and potentially lead to a useful treatment for patients with LS.

• #2 Achondroplasia Treatment – MU Health Care – Columbia, MO

  https://www.muhealth.org/conditions-treatments/pediatrics/orthopaedics/skeletal-dysplasia/achondroplasia

  Achondroplasia is a form of disproportionate dwarfism that is characterized by shortened limbs (particularly in the upper arms and legs), enlarged head with frontal bossing, midface hypoplasia and bowed legs. […] Treatment of symptoms might include monitoring and surgery by doctors who specialize in skeletal dysplasia. […] Limb-lengthening surgery should only be discussed when the patient is old enough to weigh the risks and benefits. […] Curvature of the spine can be treated with a brace or, less frequently, with spinal fusion surgery. […] Surgery might be necessary to address leg alignment problems. […] Growth should be monitored using achondroplastic growth, weight, weight-by-height and BMI charts. Limb-lengthening can be used to increase stature but should only be performed by surgeons trained in skeletal dysplasias.

• #2 Achondroplasia Treatment & Management: Approach Considerations, Medical Care, Surgical Care

  https://emedicine.medscape.com/article/1258401-treatment

  Approval was supported by outcomes of a global randomized double-blind placebo-controlled phase 3 study evaluating efficacy and safety in 121 children (age, 5-14 y) with achondroplasia over a period of 52 weeks. […] Other agents being evaluated for potential use in treating achondroplasia include FGFR3-selective tyrosine kinase inhibitors, anti-FGFR3 antibodies, aptamers against fibroblast growth factor 2 (FGF2), and soluble forms of FGFR3. […] Most of the orthopedic problems encountered in patients with achondroplasia are related to the spine. […] Surgical correction of genu varum may be required. […] Limb lengthening of the upper and lower extremities is promoted in Europe. […] If lengthening is to be performed, any existing angular deformities should be corrected simultaneously.

• #2 Dwarfism (Skeletal Dysplasia) & Other Causes of Short Stature

  https://my.clevelandclinic.org/health/diseases/17862-skeletal-dysplasia-dwarfism-and-other-causes-of-short-stature

  Dwarfism (skeletal dysplasia) is a medical term that covers hundreds of conditions that affect the growth of bone and/or cartilage, and the size of a persons arms, legs, abdomen and head. Treatment manages symptoms and leads to a normal lifespan for many types. […] Treatment for dwarfism (skeletal dysplasia) is unique for each person based on their specific diagnosis and addresses symptoms of the condition, since theres no cure. […] Surgical treatment to address symptoms could include surgery to: Correct bones growing in an abnormal direction or the shape of bones. Remove excess fluid from around the brain (hydrocephalus). Reduce brain stem compression, which is pressure on the part of the brain that connects to the spinal cord. Improve breathing by removing tonsils and/or adenoids. Add tubes in the ears to prevent ear infections.

• #2 Dwarfism: Types, Causes, and More

  https://www.healthline.com/health/dwarfism

  Physical therapy and orthotics are noninvasive solutions to some complications of dwarfism. Physical therapy is often prescribed after limb or back surgery to help you regain or improve your range of motion and strength. Physical therapy may also be advised if dwarfism is affecting the way you walk or is causing you pain that doesnt require surgery. […] Orthotics are custom-made devices that fit into your shoes to help improve your foot health and function. If dwarfism is affecting your balance, how you walk, or other aspects of foot function, talk with a podiatrist about how orthotics may help you.

• #2 Dr Satish Pediatric Orthopedic Doctor | Dwarfism

  https://www.drsatishortho.com/orthopedic-conditions/paediatric-orthopaedics/dwarfism

  Girls with Turner’s syndrome require estrogen therapy and other hormones to reach puberty. […] Surgical options are recommended in people with disproportionate dwarfism to: […] These are non-invasive methods to prevent complications associated with dwarfism. Physical therapy helps to regain strength and range of motion following limb or back surgery. […] Orthotics are customized devices that fit into the shoes to improve the foot’s health and function. They help individuals who have problems with balance and other aspects of foot function.

• #2 Dwarfism (Skeletal Dysplasia) & Other Causes of Short Stature

  https://my.clevelandclinic.org/health/diseases/17862-skeletal-dysplasia-dwarfism-and-other-causes-of-short-stature

  Other types of treatment to address symptoms of dwarfism (skeletal dysplasia) that dont involve surgery include: Using a CPAP (continuous positive airway pressure) machine for sleep apnea. Using hearing aids to improve hearing. Encouraging healthy eating habits and exercise to prevent excess weight gain or obesity (a BMI, or body mass index, of 30 or higher). Taking growth hormones (hormone therapy) to treat a growth hormone deficiency. In 2021, the U.S. Food and Drug Administration approved the use of vosoritide (Voxzogo) in children with achondroplasia who are 5 years and older but whose bone growth plates are still open (this means theyre not finished growing yet). In a clinical trial, vosoritide helped speed childrens growth. […] Treatment for dwarfism is lifelong and helps improve a persons quality of life.

• #2 Achondroplasia Treatment & Management: Approach Considerations, Medical Care, Surgical Care

  https://emedicine.medscape.com/article/1258401-treatment

  A potential exists for major complications during six-segment lengthening. […] Significant improvement of severe neurologic symptoms has been reported with foramen magnum decompression and C1 laminectomy; however, prophylactic surgery is not recommended. […] Nutritional counseling is helpful. Obesity is a lifelong issue, and dietary therapy should be initiated early in life.

• #2

  https://link.springer.com/article/10.1007/s12325-023-02549-3

  In 2021, vosoritide (Voxzogo), a C-type natriuretic peptide (CNP) analogue, was approved for use in children with achondroplasia in the European Union, US and Brazil. […] A favourable effect on change in height was reported for all identified interventions. […] Vosoritide and GH therapy conferred benefits for height or growth velocity, but the longer-term effects of GH were unclear because of evidence of trends of a waning effect over time. […] The efficacy of vosoritide was found to be maintained for up to five years, suggestive of cumulative benefits of this newly approved therapy. […] However, this finding was only reported in two trials and two extension studies. […] Current best practice for disease management is lifelong multidisciplinary care with a high risk of invasive procedures over the lifetime. […] There is a clear unmet need for studies such as economic evaluations that consider all relevant inputs for assessing the burden of achondroplasia.

• #2 Dwarfism: Types, Causes, and More

  https://www.healthline.com/health/dwarfism

  Dwarfism, regardless of the cause, cant be cured or corrected. However, there are certain therapies that may help reduce the risk of complications. […] For people with growth hormone deficiency, injections of synthetic human growth hormone may be helpful. Children receiving this treatment dont always reach an average height, but they can get close. […] Girls with Turners syndrome need estrogen therapy and other hormones to help trigger puberty and appropriate female development. Estrogen therapy may be necessary until a woman reaches the age of menopause. […] For others with dwarfism, surgical treatments may be necessary and helpful to living a longer, healthier life. […] Surgical treatments include those that can help: correct the direction of bone growth, stabilize the spine, increase the channel in the vertebrae surrounding the spinal cord to relieve pressure on the spinal cord.

• #2 Achondroplasia Treatment West Palm Beach, FL | Dwarfism Treatment New Yrok, NY

  https://www.davidsfeldmanmd.com/achondroplasia-orthopedic-surgeon-west-palm-beach.html

  An inheritable, short limbed, disproportionate form of dwarfism caused by the bodys inability to convert cartilage into bone, especially in the long bones. […] Therefore the discussion of prevention and treatment of spinal problems (stenosis), the need for stable joints with straight legs and the conversation if increased height is desired and how this is accomplished is the emphasis of my practice. […] These early interventions will have an impact on the achondroplastic individuals life forever. Yearly, and extending into adulthood, asking related questions is very important to determine if treatment is needed. […] Deformity correction is performed to avoid arthritis later in life and involves straightening of the lower legs (tibia and fibula) and/or straightening of the forearm (radius and ulna).

• #2 Dwarfism – MD Searchlight

  https://mdsearchlight.com/genetic-disorders/dwarfism/

  The side effects when treating Dwarfism can include: – Potential predisposition to type-2 diabetes – Benign intracranial hypertension – Edema/carpal tunnel syndrome – Slipped capital femoral epiphysis (SCFE) – Scoliosis – Prepubertal gynecomastia. […] People who are naturally shorter can expect to live healthy lives. Those with Growth Hormone Deficiency (GHD) can improve with treatment involving a synthetic version of human growth hormone. Starting this treatment before puberty often allows these patients to reach heights similar to their parents. However, if the short height is due to genetic or bone disorders, it can’t be reversed and will be a lifelong condition.

• #2 New Achondroplasia treatments 2025 | Everyone.org

  https://everyone.org/explore/treatment/?id=97

  Voxzogo, also known as vosoritide, is a groundbreaking FDA-approved medication specifically indicated for the treatment of achondroplasia in children aged 5 years and older whose growth plates are still open. […] Clinical trials have demonstrated that Voxzogo significantly increases growth velocity, leading to improved height outcomes in children with achondroplasia. […] Limb-lengthening surgery is an invasive procedure aimed at increasing limb length and overall stature in individuals with achondroplasia. […] Although effective in significantly increasing height, limb-lengthening surgery carries risks such as infection, nerve damage, and prolonged recovery periods. […] Growth hormone therapy has been utilized off-label to attempt to improve growth velocity in children with achondroplasia.

Zobacz więcej